219 related articles for article (PubMed ID: 7956623)
1. Apolipoprotein A-IV levels and phenotype distribution in NIDDM.
Vergès BL; Vaillant G; Goux A; Lagrost L; Brun JM; Gambert P
Diabetes Care; 1994 Aug; 17(8):810-7. PubMed ID: 7956623
[TBL] [Abstract][Full Text] [Related]
2. Macrovascular disease is associated with increased plasma apolipoprotein A-IV levels in NIDDM.
Vergès BL; Lagrost L; Vaillant G; Petit JM; Cohen M; Gambert P; Brun JM
Diabetes; 1997 Jan; 46(1):125-32. PubMed ID: 8971092
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein A-IV in diabetes mellitus.
Verges B
Diabete Metab; 1995 Apr; 21(2):99-105. PubMed ID: 7621979
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of plasma high-density lipoprotein subfractions (HDL2, HDL3) in non-insulin-dependent diabetics with coronary artery disease.
Bakogianni MC; Kalofoutis CA; Skenderi KI; Kalofoutis AT
J Diabetes Complications; 2001; 15(5):265-9. PubMed ID: 11522502
[TBL] [Abstract][Full Text] [Related]
5. ApoA-IV polymorphism associated with myocardial infarction in obese NIDDM patients. The San Luis Valley Diabetes Study.
Rewers M; Kamboh MI; Hoag S; Shetterly SM; Ferrell RE; Hamman RF
Diabetes; 1994 Dec; 43(12):1485-9. PubMed ID: 7958503
[TBL] [Abstract][Full Text] [Related]
6. Inefficiency of insulin therapy to correct apolipoprotein A-I metabolic abnormalities in non-insulin-dependent diabetes mellitus.
Duvillard L; Pont F; Florentin E; Gambert P; Vergès B
Atherosclerosis; 2000 Sep; 152(1):229-37. PubMed ID: 10996359
[TBL] [Abstract][Full Text] [Related]
7. Lipoproteins and apolipoproteins in young nonobese Arab women with NIDDM treated with insulin.
Al-Muhtaseb N; Al-Yusuf AR; Abdella N; Fenech F
Diabetes Care; 1989 May; 12(5):325-31. PubMed ID: 2656141
[TBL] [Abstract][Full Text] [Related]
8. High density lipoprotein apolipoprotein AI kinetics in NIDDM: a stable isotope study.
Frénais R; Ouguerram K; Maugeais C; Mahot P; Maugère P; Krempf M; Magot T
Diabetologia; 1997 May; 40(5):578-83. PubMed ID: 9165227
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein A-IV polymorphism in Saami and Finns: frequency and effect on serum lipid levels.
Lehtinen S; Luoma P; Näyhä S; Hassi J; Ehnholm C; Nikkari T; Peltonen N; Jokela H; Koivula T; Lehtimäki T
Ann Med; 1998 Apr; 30(2):218-23. PubMed ID: 9667802
[TBL] [Abstract][Full Text] [Related]
10. Hypertriglyceridemia in different degrees of glucose intolerance in a Finnish population-based study.
Salomaa VV; Tuomilehto J; Jauhiainen M; Korhonen HJ; Stengård J; Uusitupa M; Pitkanen M; Penttila I
Diabetes Care; 1992 May; 15(5):657-65. PubMed ID: 1516486
[TBL] [Abstract][Full Text] [Related]
11. Association of apolipoprotein A-V concentration with apolipoprotein A5 gene -1131T>C polymorphism and fasting triglyceride levels.
Kim JY; Kim OY; Paik JK; Lee SH; Lee JH
J Clin Lipidol; 2013; 7(2):94-101. PubMed ID: 23415427
[TBL] [Abstract][Full Text] [Related]
12. Acute hyperinsulinaemia decreases cholesterol synthesis less in subjects with non-insulin-dependent diabetes mellitus than in non-diabetic subjects.
Naoumova RP; Cummings MH; Watts GF; Rendell NB; Taylor GW; Sönksen PH; Thompson GR
Eur J Clin Invest; 1996 Apr; 26(4):332-40. PubMed ID: 8732493
[TBL] [Abstract][Full Text] [Related]
13. High density lipoprotein (HDL) metabolism in noninsulin-dependent diabetes mellitus: measurement of HDL turnover using tritiated HDL.
Golay A; Zech L; Shi MZ; Chiou YA; Reaven GM; Chen YD
J Clin Endocrinol Metab; 1987 Sep; 65(3):512-8. PubMed ID: 3114304
[TBL] [Abstract][Full Text] [Related]
14. Different relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients.
Zhao D; Yang LY; Wang XH; Yuan SS; Yu CG; Wang ZW; Lang JN; Feng YM
Cardiovasc Diabetol; 2016 Sep; 15(1):132. PubMed ID: 27620179
[TBL] [Abstract][Full Text] [Related]
15. Whole-plasma and high-density lipoprotein subfraction surface lipid composition in IDDM men.
Bagdade JD; Subbaiah PV
Diabetes; 1989 Oct; 38(10):1226-30. PubMed ID: 2507376
[TBL] [Abstract][Full Text] [Related]
16. Association of apolipoprotein M with high-density lipoprotein kinetics in overweight-obese men.
Ooi EM; Watts GF; Chan DC; Nielsen LB; Plomgaard P; Dahlbäck B; Barrett PH
Atherosclerosis; 2010 May; 210(1):326-30. PubMed ID: 20031132
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein analyses in varying degrees of glucose tolerance. Comparison between non-insulin-dependent diabetic, impaired glucose tolerant, and control populations.
Falko JM; Parr JH; Simpson RN; Wynn V
Am J Med; 1987 Oct; 83(4):641-7. PubMed ID: 3674053
[TBL] [Abstract][Full Text] [Related]
18. Normalization of lipoprotein composition by intraperitoneal insulin in IDDM. Role of increased hepatic lipase activity.
Ruotolo G; Parlavecchia M; Taskinen MR; Galimberti G; Zoppo A; Le NA; Ragogna F; Micossi P; Pozza G
Diabetes Care; 1994 Jan; 17(1):6-12. PubMed ID: 8112191
[TBL] [Abstract][Full Text] [Related]
19. Serum lipids and lipoprotein(a) concentrations in Chinese NIDDM patients. Relation to metabolic control.
Chang CJ; Kao JT; Wu TJ; Lu FH; Tai TY
Diabetes Care; 1995 Aug; 18(8):1191-4. PubMed ID: 7587858
[TBL] [Abstract][Full Text] [Related]
20. Postprandial responses of plasma lipids and lipoproteins in subjects with apoA-I(Lys107-->0).
Tilly-Kiesi M; Lichtenstein AH; Rintarahko J; Taskinen MR
Atherosclerosis; 1998 Mar; 137(1):37-47. PubMed ID: 9568735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]